Accure Is Here.
At Accure, we are wholly committed to developing revolutionary solutions to address acne. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.
Committed to Science and Safety
-
Clinical Trials
-
Over 6 IRB-approved trials with 100+ subjects treated
-
Face Trials
-
Back Trials
-
Focal Treatments
-
Split-Face Treatments
-
Mid/Lower Face Treatments
-
All Fitzpatrick Skin Types
-
-
Safety
-
Over 50,000 trigger pulls (1 trigger pull = 6 pulses) performed with no unexpected adverse events
-
Device designed to only deliver to Peak Epidermal Temperature (PET) target, with auto shut-off if temperature approaches safety limit. (pat. protected.)
-
A Significant Clinical Response
-
Treatment regimen will be customized to the individual patient and could range from 1 to 6 treatment sessions administered approximately 3 to 6 weeks apart.
-
This clinical study treatment regimen consists of a total of four treatment sessions, each approximately 4 weeks apart. These subjects were part of an IRB-approved pilot study with a specific treatment area as noted in the photos.
A Pioneering Technology
A truly differentiated and protected product for clinicians worldwide
The Accure Laser has been granted both CE Mark approval and FDA clearance for the treatment of inflammatory acne vulgaris.
-
Treat-To-Temperature: A Paradigm Change
A closed-loop system that uses an advanced, predictive thermal monitoring and modulation platform to target and thermally damage sebaceous glands.
-
Easy To Use
Provides an elegant and simple interface for providers and their extenders to deliver safe, consistent, and reproducible treatments.